FDAnews Device Daily Bulletin

NUVASIVE ACQUIRES ADDITIONAL TECHNOLOGY RIGHTS

Aug. 22, 2005
A A

NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today the acquisition of assets and intellectual property from RiverBend Design LLC. The acquired intellectual property includes a patent application and related technology for use in developing dynamic stabilization products. NuVasive made a closing payment to RiverBend of 51,308 unregistered shares of NuVasive common stock. NuVasive will also make royalty payments to RiverBend for sales of products based on the technology. The research and development costs associated with this project are expected to be immaterial.

MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqWk2qbWbmJi5CdK0mZq)